The collection of scientific articles published in 2025 showcases the transformative role of CRISPR technology in genomics and biotechnology, highlighting its diverse applications and methodological advancements.

In the study of porcine embryos, CRISPR/Cas9 emerges as a pivotal tool for genetic modification, with methodologies like somatic cell nuclear transfer and microinjection being explored. Despite its promise, challenges such as off-target effects and mosaicism persist, necessitating further refinement to enhance agricultural and biomedical applications.

The integration of CRISPR-Cas12a with DNAzyme-triggered systems in nucleic acid diagnostics offers a simplified one-pot solution, overcoming the complexity and efficiency issues of current methods. This advancement holds potential for broadening the scope of CRISPR-based diagnostic tools.

In the fight against antibiotic-resistant superbugs, CRISPR-Cas systems facilitate precise bacteriophage genome editing, enhancing their efficacy and specificity. This approach, coupled with phage cocktails and phage-antibiotic combinations, presents a promising strategy for combating antibiotic resistance.

In plant genomics, CRISPR/Cas9-mediated prime editing has enabled efficient in situ epitope tagging in rice, broadening the toolkit for gene function studies and genetic improvements. Additionally, novel cytidine deaminases expand the capabilities of base editors, enhancing precision and reducing off-target effects in rice.

The EXPERT system represents a significant leap in prime editing, allowing large fragment edits with improved efficiency and minimal off-target effects, thus expanding the editing range for biotechnological applications.

CRISPR/Cas9-mediated editing of the BCL11B gene in CAR-engineered lymphoid progenitors demonstrates prolonged anti-leukemic activity, offering insights into novel cancer therapies.

In Fusarium circinatum research, CRISPR-Cas9 elucidates the role of the Pgs gene in pathogenicity, growth, and sporulation, paving the way for deeper understanding and control of this destructive pathogen.

Together, these studies underscore CRISPR's versatility and potential in advancing genomics and biotechnology, driving innovations across diagnostics, agriculture, and therapeutic development.